Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -546,376 | -506,005 | -468,005 | -426,075 | -309,851 |
| Depreciation Amortization | 397,047 | 392,858 | 389,379 | 386,073 | 224,807 |
| Income taxes - deferred | -546 | -546 | -546 | -546 | -205 |
| Accounts receivable | -7,924 | -3,092 | -4,733 | -4,121 | 9,091 |
| Accounts payable and accrued liabilities | 2,482 | 761 | -505 | -1,525 | 1,405 |
| Other Working Capital | 4,442 | -3,051 | -6,258 | -2,387 | -40,578 |
| Other Operating Activity | 39,666 | 26,935 | 17,235 | 4,525 | -90,727 |
| Operating Cash Flow | $-111,209 | $-92,140 | $-73,433 | $-44,056 | $-206,058 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 123,162 | 96,272 | 77,456 | 51,623 | 130,192 |
| PPE Investments | -2,714 | -1,853 | -1,939 | -1,389 | -6,188 |
| Purchase Sale Intangibles | -5,000 | -5,000 | -5,000 | -5,000 | N/A |
| Other Investing Activity | -5,000 | -5,000 | -5,000 | -5,000 | 0 |
| Investing Cash Flow | $115,448 | $89,419 | $70,517 | $45,234 | $124,004 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -490 |
| Common Stock Issued | 3,428 | 3,428 | 1,959 | 1,959 | 7,703 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -50,200 |
| Financing Cash Flow | $3,428 | $3,428 | $1,959 | $1,959 | $-42,987 |
| Beginning Cash Position | 57,592 | 57,592 | 57,592 | 57,592 | 182,633 |
| End Cash Position | 65,259 | 58,299 | 56,635 | 60,729 | 57,592 |
| Net Cash Flow | $7,667 | $707 | $-957 | $3,137 | $-125,041 |
| Free Cash Flow | |||||
| Operating Cash Flow | -111,209 | -92,140 | -73,433 | -44,056 | -206,058 |
| Capital Expenditure | -2,714 | -1,853 | -1,939 | -1,389 | -6,188 |
| Free Cash Flow | -113,923 | -93,993 | -75,372 | -45,445 | -212,246 |